NCT00050622View on ClinicalTrials.gov

Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

NACompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

August 31, 2004

Study Completion Date

June 30, 2005

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Methylphenidate 0.15 mg/kg

0.15 m/kg/dose immediate-release methylphenidate

BEHAVIORAL

Low-Intensity BMOD

Lower-intensity behavioral treatment package.

DRUG

Methylphenidate 0.3 mg/kg

0.3 mg/kg/dose immediate-release methylphenidate

DRUG

Placebo

DRUG

Methylphenidate 0.6 mg/kg

0.3 mg/kg/dose immediate-release methylphenidate

BEHAVIORAL

High Intensity BMOD

Comprehensive high-intensity Summer Treatment Program (STP)

Trial Locations (2)

14214

Center for Children and Families, University at Buffalo, Buffalo

33199

Florida International University Center for Children and Families, Miami

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Florida International University

OTHER

NCT00050622 - Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter